MYC RNA+YTHDC1 Targeted therapy(Transition Bio)

N/A

Report date: 2024/12/09 16:52:41

NME

Base Information

Drug NameMYC RNA+YTHDC1 Targeted therapy(Transition Bio)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionYTH N6-Methyladenosine RNA Binding Protein C1 modulators

TargetsYTH N6-Methyladenosine RNA Binding Protein C1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTransition Bio Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A